期刊
TOXINS
卷 12, 期 3, 页码 -出版社
MDPI
DOI: 10.3390/toxins12030151
关键词
chronodisruption; chronodisruptor; circadian rhythm; internal clock; chronic kidney disease
资金
- FIS [CP14/00133, PI16/02057, PI18/01366, PI19/00588, PI19/00815, DTS18/00032]
- ERA-PerMed-JTC2018 [AC18/00064, AC18/00071]
- National Institute of Health [2R01AI063331]
- ISCIII-RETIC REDinREN Fondos FEDER [RD016/0009]
- FRIAT
- Sociedad Espanola de Nefrologia, Comunidad de Madrid [B2017/BMD-3686 CIFRA2-CM]
- Miguel Servet [MS14/00133]
- IIS-Fundacion Jimenez Diaz Biobank, part of the Spanish Biobanks Platform [PT17/0015/0006]
Multiple physiological variables change over time in a predictable and repetitive manner, guided by molecular clocks that respond to external and internal clues and are coordinated by a central clock. The kidney is the site of one of the most active peripheral clocks. Biological rhythms, of which the best known are circadian rhythms, are required for normal physiology of the kidneys and other organs. Chronodisruption refers to the chronic disruption of circadian rhythms leading to disease. While there is evidence that circadian rhythms may be altered in kidney disease and that altered circadian rhythms may accelerate chronic kidney disease (CKD) progression, there is no comprehensive review on chronodisruption and chronodisruptors in CKD and its manifestations. Indeed, the term chronodisruption has been rarely applied to CKD despite chronodisruptors being potential therapeutic targets in CKD patients. We now discuss evidence for chronodisruption in CKD and the impact of chronodisruption on CKD manifestations, identify potential chronodisruptors, some of them uremic toxins, and their therapeutic implications, and discuss current unanswered questions on this topic.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据